Literature DB >> 1888829

Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication.

J Weil1, G D Bell, K Powell, A Morden, G Harrison, P W Gant, P H Jones, J E Trowell.   

Abstract

Twenty-four Helicobacter pylori (H. pylori)-positive patients were treated for 28 days with either 20 mg omeprazole o.m. (n = 12) or 40 mg omeprazole o.m. (n = 12). Clearance (absence of H. pylori at the end of or shortly after treatment) and eradication (absence of H. pylori 1 month after cessation of treatment) were assessed using the 14C-urea breath test. Observed clearance and eradication were: 20 mg omeprazole 3/12 and 0/12; 40 mg omeprazole 6/12 and 1/12 respectively. The effect on H. pylori is probably due to the change in gastric pH from acid to neutral, however it is insufficient to recommend the inclusion of omeprazole in regimens aimed at eradicating H. pylori.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1888829     DOI: 10.1111/j.1365-2036.1991.tb00032.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  20 in total

Review 1.  Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes.

Authors:  H X Xia; N J Talley; C T Keane; C A O'Morain
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

2.  Evaluation of methods for H. pylori detection in PPI consumption using culture, rapid urease test and smear examination.

Authors:  Farideh Siavoshi; Parastoo Saniee; Saman Khalili-Samani; Farideh Hosseini; Fahimeh Malakutikhah; Marzieh Mamivand; Somayeh Shahreza; Amir Houshang Sharifi
Journal:  Ann Transl Med       Date:  2015-01

3.  Comparison of serum, salivary, and rapid whole blood diagnostic tests for Helicobacter pylori and their validation against endoscopy based tests.

Authors:  T G Reilly; V Poxon; D S Sanders; T S Elliott; R P Walt
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

4.  H. pylori-negative duodenal ulcer prevalence and causes in 774 patients.

Authors:  J P Gisbert; M Blanco; J M Mateos; L Fernández-Salazar; M Fernández-Bermejo; J Cantero; J M Pajares
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

Review 5.  Gastroenterology--I: Gastroduodenal disease and Helicobacter pylori.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

6.  Alternative method for transporting and storing gastric biopsy cultures of Helicobacter pylori.

Authors:  A Savio
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

7.  Serology and urea breath test in the diagnosis of H. pylori infection.

Authors:  P R Hawtin
Journal:  Mol Biotechnol       Date:  1999-02       Impact factor: 2.695

8.  Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole.

Authors:  R P Logan; M M Walker; J J Misiewicz; P A Gummett; Q N Karim; J H Baron
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

9.  DNA fingerprints of Helicobacter pylori before and after treatment with omeprazole.

Authors:  A G Fraser; J Bickley; R J Owen; R E Pounder
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

Review 10.  Effects of acid suppression on microbial flora of upper gut.

Authors:  N D Yeomans; R W Brimblecombe; J Elder; R V Heatley; J J Misiewicz; T C Northfield; A Pottage
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.